Editorial

By Thomas Green Bonaventure —an integrated alternative asset management firm with over $2.3 billion of...

    By Healthcare Edge Editorial Staff SAB Biotherapeutics, Inc. (Nasdaq: SABS), which is trying...

PE Edge and Exec Edge are please to provide complete video coverage of the third...

Healthcare Edge and Exec Edge are please to provide complete video coverage of the third...

PE Edge and Exec Edge are please to provide complete video coverage of the third...

The new book for aspiring day traders uses honesty to dispel myths and discourage anyone...

By Karen E. Roman Alladapt Immunotherapeutics, Inc., a biopharmaceutical company developing treatment for Immunoglobulin E-mediated...

IPO Edge hosted a fireside chat with Chief Executive Officer Michael Seifert of PublicSq (NYSE:...

By PE Edge Editorial Staff Hodes Weill & Associates and Cornell University published their annual...

By Exec Edge Editorial Staff Iran’s interference in Iraq’s internal politics has been pernicious and...